NPI: 1366478919 · BROOKLYN, NY 11203 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 06/24/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (ASSISTANT SECRETARY) |
| NPI Enumeration Date | 06/24/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 10,127 | $267K |
| 2019 | 24,546 | $1.11M |
| 2020 | 33,485 | $1.70M |
| 2021 | 15,305 | $733K |
| 2022 | 11,861 | $505K |
| 2023 | 7,449 | $649K |
| 2024 | 5,541 | $477K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 17,216 | 1,827 | $3.71M |
| A4657 | Syringe, with or without needle, each | 38,519 | 2,735 | $1.48M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 41,605 | 1,437 | $212K |
| J1270 | Injection, doxercalciferol, 1 mcg | 3,162 | 313 | $16K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 538 | 170 | $11K |
| 83970 | 2,499 | 531 | $4K | |
| J1756 | Injection, iron sucrose, 1 mg | 607 | 162 | $2K |
| 82728 | 2,026 | 224 | $2K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 596 | 95 | $986.42 |
| 82108 | 976 | 93 | $960.00 | |
| 85041 | 514 | 82 | $650.30 | |
| G0008 | Administration of influenza virus vaccine | 14 | 13 | $136.07 |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 42 | 24 | $71.20 |